Sectors + Companies

Budget Battles

  • Senator Ben Cardin (D-MD) arrives at Democratic Party caucus meeting on Capitol Hill in Washington, U.S., January 19, 2018. REUTERS/Yuri Gripas/ File Photo

    Factbox: What happens in a U.S. government shutdown?

    By Richard Cowan and Susan Cornwell and Amanda Becker and Richard Cowan and Susan Cornwell and Amanda Becker, Reuters

    In shutdowns, nonessential government employees are furloughed, or placed on temporary unpaid leave. Workers deemed essential, including those dealing with public safety and national security, keep...

  • FILE PHOTO: A pharmacist holds prescription painkiller OxyContin at a local pharmacy in Provo

    Delaware Sues Opioid Manufacturers, Distributors Over Epidemic

    By Nate Raymond, Reuters

    (Reuters) - Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making,...

  • usFILE PHOTO: A bulldozer moves coal at the Murray Energy Corporation port facility in Powhatan Point, Ohio

    Trump's Coal Job Push Stumbles in Most States

    By Valerie Volcovici, Reuters

    WASHINGTON (Reuters) - President Donald Trump's effort to put coal miners back to work stumbled in most coal producing states last year, even as overall employment in the downtrodden sector grew...

  • FILE PHOTO - Treasury Secretary Steve Mnuchin listens as U.S. President Donald Trump hosts a tax reform industry meeting at the White House in Washington, U.S., October 31, 2017. REUTERS/Kevin Lamarque

    Trump Tries to Sell Tax Reform to Democrats

    By David Morgan, Reuters

    WASHINGTON (Reuters) - President Donald Trump intensified his efforts to sell Democrats on his tax reform plan on Wednesday even as Senate Republicans edged closer to passing a budget measure that...

  • FILE PHOTO: U.S. Homeland Security Secretary Jeh Johnson (L) listens to Representative Tom Marino (R-PA) (R) before a House Judiciary committee hearing on the 'Oversight of the US Department of Homeland Security' on Capitol Hill in Washington July 14, 20

    Trump's drug czar nominee withdraws from consideration

    By Sarah N. Lynch and Makini Brice, Reuters

    WASHINGTON (Reuters) - The U.S. lawmaker who was President Donald Trump's pick for drug czar withdrew on Tuesday after a report he spearheaded a bill that hurt the government's ability to crack down...

  • Japan first-quarter growth hits over two-year high

    Japan first-quarter growth hits over two-year high

    By Stanley White and Tetsushi Kajimoto, Reuters

    TOKYO (Reuters) - Japan's economy clocked its fastest pace of growth in more than two years in the first quarter as consumer spending jumped and business investment turned surprisingly strong in a...

  • Japan's working poor left behind by Abenomics

    Japan's working poor left behind by Abenomics

    By Chang-Ran Kim, Reuters

    TOKYO (Reuters) - Last Christmas Eve, Ririko Saito and her 11-year-old daughter gathered some plastic bottles, pots and a kettle and made several trips to a nearby park to get water. Their utility...

  • White House urges dialogue, not intimidation in China rig dispute

    White House urges dialogue, not intimidation in China rig dispute

    By David Brunnstrom and Steve Holland, Reuters

    WASHINGTON (Reuters) - The White House said on Wednesday that a dispute between China and Vietnam that erupted within days of President Barack Obama's visit to Asia to address regional tensions needs...

  • How Alibaba Could Challenge Amazon, eBay, Facebook and Google

    By John Aziz, TheWeek.com

    Last week, the Chinese e-commerce giant Alibaba Group filed documents for an IPO seeking to raise capital in America. The details revealed in those documents illustrate why the IPO is now widely...

  • AstraZeneca leaves door ajar to Pfizer, despite hurdles

    AstraZeneca leaves door ajar to Pfizer, despite hurdles

    By Ben Hirschler, Reuters

    LONDON (Reuters) - AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's operations into the U.S. company's...